Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. (Q38992054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Q H Miow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

J Ye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

J A Lau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

T Yokomizo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

J-P Thiery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

S Mori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

English

0 references

publication date

26 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

1899-1907

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24858042%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Ovarian cancer: strategies for overcoming resistance to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Latest research and treatment of advanced-stage epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Surgical management of recurrent ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

The resurgence of platinum-based cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epithelial-mesenchymal transition in ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epithelial-mesenchymal transitions in development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epithelial to mesenchymal transition and breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

The basics of epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cell-type-specific responses to chemotherapeutics in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Integrated genomic analyses of ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

A signature-based method for indexing cell cycle phase distribution from microarray profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cellular and molecular determinants of cisplatin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Oxidative stress as a mediator of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Curing metastatic cancer: lessons from testicular germ-cell tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

N-cadherin expression in malignant germ cell tumours of the testis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Crosstalk in NF-κB signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

The transcription factor nuclear factor-kappa B and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Adjusting batch effects in microarray expression data using empirical Bayes methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Isolation of p53-target genes and their functional analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.136

Cell-cycle progression and response of germ cell tumors to cisplatin in vitro

31 March 2020

1 reference

12 December 2020

High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy

1 reference

12 December 2020

NF-κB and cancer: a paradigm of Yin-Yang.

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

Intermediate filament proteins in human testis and testicular germ-cell tumors.

1 reference

12 December 2020

Targeting slow-proliferating ovarian cancer cells.

1 reference

12 December 2020

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

1 reference

12 December 2020

The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells

1 reference

12 December 2020

Reduced Inhibition of DNA Synthesis and G(2) Arrest during the Cell Cycle of Resistant HeLa Cells in Response to cis-Diamminedichloroplatinum

1 reference

12 December 2020

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

1 reference

12 December 2020

Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks

1 reference

12 December 2020